AAPL314.89-1.33 (-0.42%) ▼|ABBV247.94-1.87 (-0.75%) ▼|ABT94.39-0.02 (-0.02%) ▼|ACN139.36+0.30 (+0.22%) ▲|ADBE224.39+1.74 (+0.78%) ▲|AMAT588.08-0.58 (-0.10%) ▼|AMD551.66+4.94 (+0.90%) ▲|AMGN363.49-0.14 (-0.04%) ▼|AMT167.77+2.77 (+1.68%) ▲|AMZN245.47-1.58 (-0.64%) ▼|AVGO399.87-1.25 (-0.31%) ▼|AXP348.91+2.19 (+0.63%) ▲|BA222.10-1.01 (-0.45%) ▼|BAC59.52+0.27 (+0.46%) ▲|BKNG179.32+3.80 (+2.17%) ▲|BLK1,043.92+24.24 (+2.38%) ▲|BMY57.47-0.47 (-0.81%) ▼|BNY152.05-0.22 (-0.14%) ▼|BRK-B493.21-2.25 (-0.45%) ▼|C140.57+1.00 (+0.72%) ▲|CAT945.55+7.16 (+0.76%) ▲|CL92.05+1.04 (+1.14%) ▲|CMCSA23.66+0.32 (+1.35%) ▲|COF202.17+2.07 (+1.03%) ▲|COP108.72+0.70 (+0.65%) ▲|COST912.14-0.84 (-0.09%) ▼|CRM165.10+2.60 (+1.60%) ▲|CSCO119.64+1.33 (+1.12%) ▲|CVS103.75+0.94 (+0.91%) ▲|CVX175.27+1.22 (+0.70%) ▲|DE595.82+2.92 (+0.49%) ▲|DHR198.65+2.67 (+1.36%) ▲|DIS96.23+0.06 (+0.06%) ▲|DUK125.63+0.37 (+0.29%) ▲|EMR139.48+1.68 (+1.22%) ▲|FDX314.96+4.12 (+1.33%) ▲|GD373.21-1.39 (-0.37%) ▼|GE356.76-2.29 (-0.64%) ▼|GEV1,074.68-0.59 (-0.05%) ▼|GILD132.44-2.41 (-1.78%) ▼|GM77.97+1.32 (+1.72%) ▲|GOOG352.71-3.53 (-0.99%) ▼|GOOGL354.86-4.03 (-1.12%) ▼|GS1,054.84-1.13 (-0.11%) ▼|HD341.99+3.26 (+0.96%) ▲|HON222.85-0.57 (-0.26%) ▼|IBM295.13-0.18 (-0.06%) ▼|INTC109.23-3.31 (-2.94%) ▼|INTU276.56+3.18 (+1.16%) ▲|ISRG408.18-3.37 (-0.82%) ▼|JNJ259.01-0.10 (-0.04%) ▼|JPM336.81+1.34 (+0.40%) ▲|KO83.16+0.53 (+0.64%) ▲|LIN528.92+3.36 (+0.64%) ▲|LLY1,196.26-20.70 (-1.70%) ▼|LMT516.58-1.69 (-0.33%) ▼|LOW214.22+1.22 (+0.57%) ▲|LRCX345.29-7.88 (-2.23%) ▼|MA522.69-0.51 (-0.10%) ▼|MCD275.25-1.25 (-0.45%) ▼|MDLZ58.30+0.00 (+0.00%) ▲|MDT83.02+0.63 (+0.76%) ▲|META672.22+40.74 (+6.45%) ▲|MMM156.14+0.80 (+0.52%) ▲|MO71.25-0.34 (-0.47%) ▼|MRK124.42-0.66 (-0.52%) ▼|MS222.96+0.83 (+0.37%) ▲|MSFT384.50+0.14 (+0.04%) ▲|MU976.90-14.75 (-1.49%) ▼|NEE87.64+0.54 (+0.61%) ▲|NFLX73.15-2.32 (-3.07%) ▼|NKE43.73+0.95 (+2.21%) ▲|NOW108.72-0.13 (-0.11%) ▼|NVDA206.12+3.34 (+1.65%) ▲|ORCL142.14-1.58 (-1.10%) ▼|PEP137.25-0.61 (-0.44%) ▼|PFE24.38+0.13 (+0.54%) ▲|PG147.95+1.10 (+0.75%) ▲|PLTR128.01-1.03 (-0.80%) ▼|PM179.75-1.42 (-0.78%) ▼|QCOM187.48-3.64 (-1.90%) ▼|RTX193.70-1.50 (-0.77%) ▼|SBUX106.52+0.11 (+0.10%) ▲|SCHW102.59+0.68 (+0.66%) ▲|SO95.58+0.41 (+0.43%) ▲|SPG219.77+0.06 (+0.03%) ▲|T21.09+0.33 (+1.58%) ▲|TMO526.24+1.53 (+0.29%) ▲|TMUS183.85+2.37 (+1.30%) ▲|TSLA408.73+2.18 (+0.54%) ▲|TXN308.26-0.28 (-0.09%) ▼|UBER76.16+1.81 (+2.43%) ▲|UNH425.25-6.43 (-1.49%) ▼|UNP286.24+1.20 (+0.42%) ▲|UPS112.62+1.88 (+1.69%) ▲|USB62.38+0.48 (+0.78%) ▲|V347.48-0.72 (-0.21%) ▼|VZ42.19+0.66 (+1.58%) ▲|WFC87.05+0.14 (+0.16%) ▲|WMT113.34+1.13 (+1.01%) ▲|XOM137.82+0.36 (+0.26%) ▲|AAPL314.89-1.33 (-0.42%) ▼|ABBV247.94-1.87 (-0.75%) ▼|ABT94.39-0.02 (-0.02%) ▼|ACN139.36+0.30 (+0.22%) ▲|ADBE224.39+1.74 (+0.78%) ▲|AMAT588.08-0.58 (-0.10%) ▼|AMD551.66+4.94 (+0.90%) ▲|AMGN363.49-0.14 (-0.04%) ▼|AMT167.77+2.77 (+1.68%) ▲|AMZN245.47-1.58 (-0.64%) ▼|AVGO399.87-1.25 (-0.31%) ▼|AXP348.91+2.19 (+0.63%) ▲|BA222.10-1.01 (-0.45%) ▼|BAC59.52+0.27 (+0.46%) ▲|BKNG179.32+3.80 (+2.17%) ▲|BLK1,043.92+24.24 (+2.38%) ▲|BMY57.47-0.47 (-0.81%) ▼|BNY152.05-0.22 (-0.14%) ▼|BRK-B493.21-2.25 (-0.45%) ▼|C140.57+1.00 (+0.72%) ▲|CAT945.55+7.16 (+0.76%) ▲|CL92.05+1.04 (+1.14%) ▲|CMCSA23.66+0.32 (+1.35%) ▲|COF202.17+2.07 (+1.03%) ▲|COP108.72+0.70 (+0.65%) ▲|COST912.14-0.84 (-0.09%) ▼|CRM165.10+2.60 (+1.60%) ▲|CSCO119.64+1.33 (+1.12%) ▲|CVS103.75+0.94 (+0.91%) ▲|CVX175.27+1.22 (+0.70%) ▲|DE595.82+2.92 (+0.49%) ▲|DHR198.65+2.67 (+1.36%) ▲|DIS96.23+0.06 (+0.06%) ▲|DUK125.63+0.37 (+0.29%) ▲|EMR139.48+1.68 (+1.22%) ▲|FDX314.96+4.12 (+1.33%) ▲|GD373.21-1.39 (-0.37%) ▼|GE356.76-2.29 (-0.64%) ▼|GEV1,074.68-0.59 (-0.05%) ▼|GILD132.44-2.41 (-1.78%) ▼|GM77.97+1.32 (+1.72%) ▲|GOOG352.71-3.53 (-0.99%) ▼|GOOGL354.86-4.03 (-1.12%) ▼|GS1,054.84-1.13 (-0.11%) ▼|HD341.99+3.26 (+0.96%) ▲|HON222.85-0.57 (-0.26%) ▼|IBM295.13-0.18 (-0.06%) ▼|INTC109.23-3.31 (-2.94%) ▼|INTU276.56+3.18 (+1.16%) ▲|ISRG408.18-3.37 (-0.82%) ▼|JNJ259.01-0.10 (-0.04%) ▼|JPM336.81+1.34 (+0.40%) ▲|KO83.16+0.53 (+0.64%) ▲|LIN528.92+3.36 (+0.64%) ▲|LLY1,196.26-20.70 (-1.70%) ▼|LMT516.58-1.69 (-0.33%) ▼|LOW214.22+1.22 (+0.57%) ▲|LRCX345.29-7.88 (-2.23%) ▼|MA522.69-0.51 (-0.10%) ▼|MCD275.25-1.25 (-0.45%) ▼|MDLZ58.30+0.00 (+0.00%) ▲|MDT83.02+0.63 (+0.76%) ▲|META672.22+40.74 (+6.45%) ▲|MMM156.14+0.80 (+0.52%) ▲|MO71.25-0.34 (-0.47%) ▼|MRK124.42-0.66 (-0.52%) ▼|MS222.96+0.83 (+0.37%) ▲|MSFT384.50+0.14 (+0.04%) ▲|MU976.90-14.75 (-1.49%) ▼|NEE87.64+0.54 (+0.61%) ▲|NFLX73.15-2.32 (-3.07%) ▼|NKE43.73+0.95 (+2.21%) ▲|NOW108.72-0.13 (-0.11%) ▼|NVDA206.12+3.34 (+1.65%) ▲|ORCL142.14-1.58 (-1.10%) ▼|PEP137.25-0.61 (-0.44%) ▼|PFE24.38+0.13 (+0.54%) ▲|PG147.95+1.10 (+0.75%) ▲|PLTR128.01-1.03 (-0.80%) ▼|PM179.75-1.42 (-0.78%) ▼|QCOM187.48-3.64 (-1.90%) ▼|RTX193.70-1.50 (-0.77%) ▼|SBUX106.52+0.11 (+0.10%) ▲|SCHW102.59+0.68 (+0.66%) ▲|SO95.58+0.41 (+0.43%) ▲|SPG219.77+0.06 (+0.03%) ▲|T21.09+0.33 (+1.58%) ▲|TMO526.24+1.53 (+0.29%) ▲|TMUS183.85+2.37 (+1.30%) ▲|TSLA408.73+2.18 (+0.54%) ▲|TXN308.26-0.28 (-0.09%) ▼|UBER76.16+1.81 (+2.43%) ▲|UNH425.25-6.43 (-1.49%) ▼|UNP286.24+1.20 (+0.42%) ▲|UPS112.62+1.88 (+1.69%) ▲|USB62.38+0.48 (+0.78%) ▲|V347.48-0.72 (-0.21%) ▼|VZ42.19+0.66 (+1.58%) ▲|WFC87.05+0.14 (+0.16%) ▲|WMT113.34+1.13 (+1.01%) ▲|XOM137.82+0.36 (+0.26%) ▲|
28.7 C
New York
Friday, July 10, 2026

Tag: research

Retirement Preparedness: Five Steps for Financially Secure Transition

### Ensuring Your Financial Security in Retirement Retirement represents a significant shift in both lifestyle and financial dynamics. It is imperative for those considering this...

BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review

STOCKHOLM, June 13, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase...

Meta Allocates $14.3B to Scale AI, Enhancing Superintelligence Model Development

Meta Platforms, Inc. has announced a strategic investment of $14.3 billion in Scale AI, a firm specializing in data-driven artificial intelligence systems. This investment...

Moomoo Launches Moomoo AI, Setting a New Benchmark for Retail Investing in Southeast Asia

Moomoo AI introduces real-time market data intelligence, a 24/7 AI Investment Assistant, and no-code automated trading tools—redefining how retail investors in Malaysia and Singapore...

Global News and The Local Win CJF Excellence Awards

TORONTO, June 12, 2025 /CNW/ - Global News is this year's recipient of the CJF Jackman Award for Excellence in Journalism in the large-media category, for...

Taiwan Goes All-In for BIO in Boston: 2025’s Pavilion Promotes Biotech Innovation, Tech Power, and Global Partnerships

BOSTON, June 11, 2025 /PRNewswire/ -- Taiwan's delegation, led by BPIPO (Biotechnology and Pharmaceutical Industries Promotion Office), organized by the Ministry of Economic Affairs, and...

DC Guaranteed Income Coalition Hosts Day of Action to Protect Critical Programs for DC Families

Event organized in response to DC Mayor Muriel Bowser cutting the Child Tax Credit for DC, Baby Bonds, Strong Families, Strong Futures pilot, and Early Childcare Funding from 2026 budget
Event organized in response to DC Mayor Muriel Bowser cutting the Child Tax Credit for DC, Baby Bonds, Strong Families, Strong Futures pilot, and Early Childcare Funding from 2026 budget

Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025

HAMPTON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of life at 76 weeks, 7 months after the completion of dosing with barzolvolimab in chronic spontaneous urticaria (CSU), an immune-related condition driven by mast cell activation. Barzolvolimab specifically targets mast cells by binding the receptor tyrosine kinase KIT with high specificity and potently inhibiting its activity, which is required for mast cell function and survival.

Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses

-- Breadth of presentations, including one oral and two flash talks, showcase Blueprint Medicines' leadership role in advancing care for patients with systemic mastocytosis...

4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight

Key companies, such as CSL Behring, Equillium, Biocon, and medac, are advancing their assets through late-stage graft versus host disease clinical trials, driving innovation...

Cancer Pain Market Set to Transform by 2034 Due to Launch of Breakthrough Therapies | DelveInsight

According to DelveInsight's analysis, the growth of the cancer pain market is expected to be mainly driven by increasing incidence and advances in disease...

Eisenhower Fellowships names 2025 Southeast Asia Fellows

Fifteen ascendant leaders from ASEAN nations to travel to U.S. this fall PHILADELPHIA, June 12, 2025 /PRNewswire/ -- Eisenhower Fellowships (EF) has selected 15 exceptional mid-career...

Pixalate Releases Global Top 25 Most Popular Connected TV (CTV) FAST Apps Reports for Q1 2025: ‘Sling TV’ No. 1 on Roku, ‘Plex’ Leads...

According to Pixalate’s research, 'Sling TV' was the most popular FAST app on Roku, while 'Plex' ranked No. 1 for Apple TV and Samsung Smart TV. 'Pluto TV' held the top position for Amazon Fire TV
According to Pixalate’s research, 'Sling TV' was the most popular FAST app on Roku, while 'Plex' ranked No. 1 for Apple TV and Samsung Smart TV. 'Pluto TV' held the top position for Amazon Fire TV

AACC, NSF Announce Winning Teams of 2025 Community College Innovation Challenge

Bergen Community College; Perimeter College at Georgia State University; and Dallas College took home winning titles following presentations of their STEM innovations to address real-world challenges WASHINGTON,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsResearch